Overexpression of both the MUC1 and FRA receptors on the breast cancer highlight the potential application of the radiolabeled MUC1-conjugated folate hybrid peptide as dual-receptor-targeting imaging probes for breast carcinoma imaging. Here, MUC1 is linked to breast carcinoma.